Physicians' Academy for Cardiovascular Education

Is inflammation reduction key for targeting residual risk, beyond lowering LDL-c?

3' education - Oct. 18, 2014 - Snapshot 2014 - Prof. Paul M Ridker, MD



Dr. Paul Ridker, Boston describes the different inflammatory pathways and ongoing clinical trials targeting inflammation
Recorded during the PAC Snapshot session in Barcelona 2014

Share this page with your colleagues and friends: